Replies to post #111137 on Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

Plain to see - outstanding company, unprecedent BOD & BOA, extremely compelling Dx and Theraputic pipeline - however the dilution is enough to choke a horse, and they're leveraged to the hilt. Way too much toxic paper strewn on the runway and the printing press is running unattended. Why the kool aid shareholders haven't put their foot down by now is beyond me...

This would all be minimized with a substantive BP contract, say $100-Mil. for 20% LymPro equity stake. The draw back to this is I don't believe they wish to encumber LymPro, due to the Dx spin out potential.

IMHO, the last 2 year small mom & pop shareholder will get wiped out on a RS - best time to get in would be post RS.

hasta leugo